Replies to post #244995 on Biotech Values

[vinmantoo]

• Slide 21 has new info about EDP-235’s live-virus potency against Omicron and other strains.

• Slide 22 has new preclinical EDP-235 info from a ferret model, including data on viral transmission from animal to animal.

I hesitate to ascribe logic to the stock market in movements in one day or a few days, but I wonder it these 2 points are part of the reasons why ENTA is up so much today. Of course, volume is very low today and was low yesterday so who knows. In any event, ENTA longs like me are happy the stock price is close to breaching $50/share again.